Protocol No.: EAA173

Title
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma
Principal Investigator
Craig, Michael
Phase
III
Age Group
Adult
Applicable Disease Site
Multiple Myeloma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Vicky Lynn, RN
Research Nurse
Phone: +1 304-293-8407

View on ClinicalTrials.gov